Covid’s Mutations & Treatments; The (New) Office with Architectural Digest
A new report suggests that Covid-19 has mutated into a new, strong strain; former head of the FDA Dr. Scott Gottlieb explains the relationship between virus mutations and increased infectiousness. Adaptive Biotechnologies CEO explains how his company is working on developing coronavirus treatments using human immune systems. Plus, office culture as we know it may change once the pandemic subsides. Features Director at Architectural Digest Sam Cochran discusses building a new normal in the workplace. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
6 Touko 202025min
Special Report | Markets in Turmoil: Pfizer Vaccine & Food Prices
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
6 Touko 202045min
Doordash CEO & the Essential Gig Economy; Reddit Co-Founder; WeWork Saga Continued
United Airlines is warning employees about job cuts after it accepted federal aid to avoid layoffs. CNBC’s Phil LeBeau reveals that this move may be just the beginning of Covid’s impact on the airline industry. Tech players big and small may have the ability to trace cases of coronavirus, but will they get permission? Reddit co-founder and venture capitalist Alexis Ohanian explains the challenge ahead for technologists as Americans weigh personal privacy against public health. Food delivery platform Doordash is teaming up with Pennsylvania’s Attorney General to keep essential delivery workers safe. The company’s CEO and the PA AG laud gig economy workers on the front lines of the pandemic. WeWork’s Adam Neumann is making headlines again; CNBC’s Deirdre Bosa discusses the latest chapter--and lawsuit--in the co-working intrigue. Plus, at-home haircuts, fridge staples’ rising costs, and social media tensions between China and the United States. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
5 Touko 202035min
Special Report | Markets in Turmoil: Airlines & Future of Sports
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
5 Touko 202045min
Warren Buffett: “Nothing can stop America”
Berkshire Hathaway’s 2020 annual shareholder meeting, the “Woodstock for Capitalists” -- which allows the company’s 40,000+ investors to question the Oracle of Omaha directly -- was hosted virtually for the first time ever. The four-hour live-streamed presentation and Q&A gave insight into Warren Buffett’s investing mindset amid the coronavirus crisis. Becky Quick joins the podcast with exclusive insight and highlights from the meeting. Chief Economic Adviser of Allianz, Mohamed El-Erian, discusses Warren Buffett’s take on the markets and the impact of the Fed’s emergency response to the coronavirus crisis. Plus, words of hope from Apple CEO Tim Cook to the class of 2020. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
4 Touko 202036min
Special Report | Markets in Turmoil: Gilead & COVID-19 Testing
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
2 Touko 202045min
Gilead’s Remdesivir, the Drug that Could Treat Covid-19
Gilead CEO Daniel O’Day shares details of Remdesivir’s two positive trials against Covid-19. He explains collaboration among global drugmakers, the process of finding a treatment for coronavirus, and worldwide, equitable distribution of the drug once it’s developed. CNBC’s Senior Health Science Reporter Meg Tirrell traces the history of Remdesivir, as well as the world’s response to pandemics in the past. In a conversation exclusive to Squawk Pod, Tirrell tracks the drugmakers still in the race for a Covid vaccine and treatment, and she explains covering the pandemic accurately amid rapidly evolving headlines. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
1 Touko 202037min
Special Report | Markets in Turmoil: Healthcare & Reopening
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
1 Touko 202044min
